150 related articles for article (PubMed ID: 20085840)
21. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial K(ATP) channels-derived reactive oxygen species activate pro-survival pathway in pravastatin-induced cardioprotection.
Thuc LC; Teshima Y; Takahashi N; Nagano-Torigoe Y; Ezaki K; Yufu K; Nakagawa M; Hara M; Saikawa T
Apoptosis; 2010 Jun; 15(6):669-78. PubMed ID: 20151195
[TBL] [Abstract][Full Text] [Related]
23. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
[TBL] [Abstract][Full Text] [Related]
24. Tempol reduces reperfusion-induced arrhythmias in anaesthetized rats.
Guo R; Gao XY; Wang W; Wang HJ; Zhang F; Zhang Y; Zhu GQ
Pharmacol Res; 2005 Aug; 52(2):192-8. PubMed ID: 15967386
[TBL] [Abstract][Full Text] [Related]
25. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide.
Wang Y; Kudo M; Xu M; Ayub A; Ashraf M
J Mol Cell Cardiol; 2001 Nov; 33(11):2037-46. PubMed ID: 11708847
[TBL] [Abstract][Full Text] [Related]
27. Nitrite-derived nitric oxide by xanthine oxidoreductase protects the liver against ischemia-reperfusion injury.
Lu P; Liu F; Yao Z; Wang CY; Chen DD; Tian Y; Zhang JH; Wu YH
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):350-5. PubMed ID: 16109514
[TBL] [Abstract][Full Text] [Related]
28. The platelet activating factor triggers preconditioning-like cardioprotective effect via mitochondrial K-ATP channels and redox-sensible signaling.
Penna C; Mognetti B; Tullio F; Gattullo D; Mancardi D; Pagliaro P; Alloatti G
J Physiol Pharmacol; 2008 Mar; 59(1):47-54. PubMed ID: 18441387
[TBL] [Abstract][Full Text] [Related]
29. Prevention of postischemic myocardial reperfusion injury by the combined treatment of NCX-4016 and Tempol.
Kutala VK; Khan M; Mandal R; Potaraju V; Colantuono G; Kumbala D; Kuppusamy P
J Cardiovasc Pharmacol; 2006 Sep; 48(3):79-87. PubMed ID: 17031260
[TBL] [Abstract][Full Text] [Related]
30. Ceramide-induced preconditioning involves reactive oxygen species.
Lecour S; Owira P; Opie LH
Life Sci; 2006 Mar; 78(15):1702-6. PubMed ID: 16293265
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms.
Hung LM; Su MJ; Chen JK
Free Radic Biol Med; 2004 Mar; 36(6):774-81. PubMed ID: 14990356
[TBL] [Abstract][Full Text] [Related]
32. Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels.
Bai Y; Muqier ; Murakami H; Iwasa M; Sumi S; Yamada Y; Ushikoshi H; Aoyama T; Nishigaki K; Takemura G; Uno B; Minatoguchi S
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):658-65. PubMed ID: 21679220
[TBL] [Abstract][Full Text] [Related]
33. The role of nitric oxide, reactive oxygen species, and protein kinase C in oxytocin-induced cardioprotection in ischemic rat heart.
Faghihi M; Alizadeh AM; Khori V; Latifpour M; Khodayari S
Peptides; 2012 Oct; 37(2):314-9. PubMed ID: 22902709
[TBL] [Abstract][Full Text] [Related]
34. Noninvasive limb ischemic preconditioning protects against myocardial I/R injury in rats.
Li SJ; Wu YN; Kang Y; Yin YQ; Gao WZ; Liu YX; Lou JS
J Surg Res; 2010 Nov; 164(1):162-8. PubMed ID: 19726056
[TBL] [Abstract][Full Text] [Related]
35. Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart.
Bugge E; Ytrehus K
J Mol Cell Cardiol; 1996 Dec; 28(12):2333-41. PubMed ID: 9004150
[TBL] [Abstract][Full Text] [Related]
36. Delayed protective effects of hyperoxia against cardiac arrhythmias and infarction in anesthetized rats.
Esmaili Dehaj M; Baharvand B; Rasoulian B; Foadaddini M; Asgari A; Noroozzadeh A; Poorkhalili K; Wahhab Aghai H; Khoshbaten A
J Surg Res; 2009 Jan; 151(1):55-61. PubMed ID: 18619620
[TBL] [Abstract][Full Text] [Related]
37. Reactive oxygen species-induced stimulation of 5'AMP-activated protein kinase mediates sevoflurane-induced cardioprotection.
Lamberts RR; Onderwater G; Hamdani N; Vreden MJ; Steenhuisen J; Eringa EC; Loer SA; Stienen GJ; Bouwman RA
Circulation; 2009 Sep; 120(11 Suppl):S10-5. PubMed ID: 19752353
[TBL] [Abstract][Full Text] [Related]
38. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J
Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
[TBL] [Abstract][Full Text] [Related]
39. A "second window of protection" occurs 24 h after ischemic preconditioning in the rat heart.
Yamashita N; Hoshida S; Taniguchi N; Kuzuya T; Hori M
J Mol Cell Cardiol; 1998 Jun; 30(6):1181-9. PubMed ID: 9689592
[TBL] [Abstract][Full Text] [Related]
40. Conditional overexpression of neuronal nitric oxide synthase is cardioprotective in ischemia/reperfusion.
Burkard N; Williams T; Czolbe M; Blömer N; Panther F; Link M; Fraccarollo D; Widder JD; Hu K; Han H; Hofmann U; Frantz S; Nordbeck P; Bulla J; Schuh K; Ritter O
Circulation; 2010 Oct; 122(16):1588-603. PubMed ID: 20921441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
